Rajendar K Mittapalli Selected Research

Temozolomide (Temodar)

12/2015

Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rajendar K Mittapalli Research Topics

Disease

19	Neoplasms (Cancer) 01/2021 - 12/2010
18	Breast Neoplasms (Breast Cancer) 01/2017 - 10/2009
16	Brain Neoplasms (Brain Tumor) 01/2017 - 10/2009
5	Glioblastoma (Glioblastoma Multiforme) 01/2017 - 10/2012
5	Melanoma (Melanoma, Malignant) 02/2016 - 07/2012
5	Neoplasm Metastasis (Metastasis) 11/2013 - 10/2009
4	Glioma (Gliomas) 01/2016 - 10/2012
2	Body Weight (Weight, Body) 01/2017 - 10/2015
2	Leukemia 04/2013 - 04/2013
1	Rheumatoid Arthritis 01/2019
1	Disease Progression 10/2018
1	Fatigue 01/2018
1	Edema (Dropsy) 01/2017
1	Fallopian Tube Neoplasms 01/2017
1	Rectal Neoplasms (Rectal Cancer) 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 08/2014
1	Brain Diseases (Brain Disorder) 06/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2013
1	Vascular Remodeling 12/2010
1	Dementia (Dementias) 10/2010
1	Neoplasm Micrometastasis 10/2009

Drug/Important Bio-Agent (IBA)

13	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2016 - 12/2010
12	Proteins (Proteins, Gene)FDA Link 02/2016 - 12/2010
10	Pharmaceutical PreparationsIBA 02/2016 - 10/2009
4	ErbB Receptors (EGF Receptor)IBA 01/2019 - 10/2015
4	ElacridarIBA 01/2016 - 04/2013
3	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 05/2017
3	VemurafenibIBA 02/2015 - 07/2012
3	Sunitinib (Sutent)FDA Link 12/2013 - 06/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2013 - 11/2009
2	Phosphotransferases (Kinase)IBA 01/2021 - 10/2012
2	Cytotoxins (Cytolysins)IBA 01/2019 - 01/2018
2	depatuxizumab mafodotinIBA 01/2019 - 01/2018
2	EpitopesIBA 01/2019 - 10/2015
2	ABT-767IBA 10/2018 - 01/2017
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2018 - 12/2015
2	Monoclonal AntibodiesIBA 01/2018 - 10/2015
2	AlbuminsIBA 01/2017 - 10/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2016 - 08/2014
2	Mitogen-Activated Protein KinasesIBA 02/2016 - 08/2014
2	Dasatinib (BMS 354825)FDA Link 01/2016 - 10/2012
2	dabrafenibIBA 08/2014 - 03/2013
2	Tyrosine Kinase InhibitorsIBA 12/2013 - 06/2013
1	Antimitotic AgentsIBA 01/2019
1	Delayed-Action PreparationsIBA 01/2019
1	Janus KinasesIBA 01/2019
1	monomethylauristatin FIBA 01/2019
1	upadacitinibIBA 01/2019
1	PlatinumIBA 10/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2018
1	ABT-414IBA 05/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	CreatinineIBA 01/2017
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2017
1	veliparibIBA 01/2017
1	AntibodiesIBA 01/2017
1	Capecitabine (Xeloda)FDA Link 01/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2016
1	omipalisibIBA 02/2016
1	TOR Serine-Threonine KinasesIBA 02/2016
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 01/2016
1	rucaparibIBA 12/2015
1	Temozolomide (Temodar)FDA LinkGeneric 12/2015
1	Cyclin-Dependent Kinase 4IBA 11/2015
1	palbociclibIBA 11/2015
1	depatuxizumabIBA 10/2015
1	epidermal growth factor receptor VIIIIBA 10/2015
1	trametinibIBA 08/2014
1	Hyaluronic Acid (Hyaluronan)IBA 11/2013
1	NanoconjugatesIBA 11/2013
1	Sorafenib (BAY 43-9006)FDA Link 06/2013
1	CytokinesIBA 06/2013
1	antineoplaston A10 (A 10)IBA 04/2013
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2013
1	Glutamic Acid (Glutamate)FDA Link 03/2013
1	Protein Kinases (Protein Kinase)IBA 03/2013
1	Threonine (L-Threonine)FDA Link 03/2013
1	Valine (L-Valine)FDA Link 03/2013
1	Rhodamine 123IBA 01/2013
1	PropaneIBA 07/2012
1	SulfonamidesIBA 07/2012
1	Lapatinib (GW572016)FDA Link 03/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2010
1	Saquinavir (Invirase)FDA Link 12/2010
1	DesminIBA 12/2010
1	Multidrug Resistance-Associated ProteinsIBA 12/2010
1	Angiopep-2IBA 11/2009
1	paclitaxel-Angiopep-2 conjugateIBA 11/2009
1	Vorinostat FDA Link 10/2009
1	Histones (Histone)IBA 10/2009

Therapy/Procedure

7	Therapeutics 02/2016 - 10/2009
5	Drug Therapy (Chemotherapy) 01/2016 - 10/2009
1	Radiotherapy 01/2017
1	Lasers (Laser) 12/2015
1	Intravenous Infusions 10/2015
1	Injections 11/2013
1	Oral Administration 03/2012
1	Highly Active Antiretroviral Therapy (HAART) 10/2010